ANDRES MANUEL R CERVANTES RUIPEREZ-rekin lankidetzan egindako argitalpenak (6)

2024

  1. ctDNA whole exome sequencing in pancreatic ductal adenocarcinoma unveils organ-dependent metastatic mechanisms and identifies actionable alterations in fast progressing patients

    Translational Research, Vol. 271, pp. 105-115

2023

  1. "Proteotranscriptomic analysis of advanced colorectal cancer patient derived organoids for drug sensitivity prediction"

    Journal of experimental & clinical cancer research : CR, Vol. 42, Núm. 1, pp. 8

2021

  1. Circulating tumor dna detection by digital-droplet pcr in pancreatic ductal adenocarcinoma: A systematic review

    Cancers, Vol. 13, Núm. 5, pp. 1-14

  2. In the literature: August 2021

    ESMO Open

  3. Molecular profiling of advanced solid tumours. The impact of experimental molecular-matched therapies on cancer patient outcomes in early-phase trials: the MAST study

    British Journal of Cancer, Vol. 125, Núm. 9, pp. 1261-1269

2020

  1. Neoadjuvant treatment for locally advanced unresectable and borderline resectable pancreatic cancer: Oncological outcomes at a single academic centre

    ESMO Open, Vol. 5, Núm. 6